Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine

Neuropharmacology

Volumn 39, Issue 9, 2000, Pages 1523-1535

  Schlichter, Rémy ^a   Rybalchenko, Volodymyr ^a   Poisbeau, Pierrick ^a   Verleye, Marc ^b   Gillardin, Jean Marie ^b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Service de Pharmacologie   (France)

Author keywords

Anxiolytic; Inhibitory post synaptic current (IPSC); Neurosteroid; Peripheral benzodiazepine receptor (PBR); PK11195

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 6 CHLORO 2 ETHYLAMINO 4 METHYL 4 PHENYL 4H 3,1 BENZOXAZINE; ANXIOLYTIC AGENT; ETOXIFINE; FLUMAZENIL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; TERT BUTYLBICYCLOPHOSPHOROTHIOATE S 35; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN CORTEX; CONTROLLED STUDY; DOSE RESPONSE; ELECTROPHYSIOLOGY; GABAERGIC SYSTEM; HEART; HYPOTHALAMUS; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SPINAL CORD DORSAL HORN; SYNAPTIC TRANSMISSION;

ANIMALS; BEHAVIOR, ANIMAL; BICUCULLINE; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING, COMPETITIVE; BRAIN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING BEHAVIOR; FLUMAZENIL; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HYPOTHALAMUS; ISOQUINOLINES; MALE; MEMBRANE POTENTIALS; MEMBRANES; NEURONS; OXAZINES; PATCH-CLAMP TECHNIQUES; POSTERIOR HORN CELLS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, GABA-A; SULFUR RADIOISOTOPES; SYNAPTIC TRANSMISSION; TETRODOTOXIN; TRANQUILIZING AGENTS;

EID: 0034078118     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00253-1     Document Type: Article

References (41)

1. 3H]PK11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. Journal of Neurochemistry. 41:1983;1744-1750.
2. A-receptor subtypes in the spinal cord: an immunohistochemical study. Journal of Neuroscience. 16:1996;283-297.
3. Boissier J.R., Simon P., Zaczinska M., Fichelle J. Etude psychopharmacologique expériementale d'une nouvelle substance psychotrope, la éthylamino-6-chloro-4-méthyl-4-phényl-4H-3,1-benzoxazine. Thérapie. 27:1972;325-338.
4. Bottenstein J.E., Sato G.H. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proceedings of the National Academy of Sciences of the United States of America. 76:1979;514-517.
5. Davies P.A., Hanna M.C., Hales T.G., Kirkness E.F. Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunits. Nature. 385:1997;820-823.
6. Defazio T., Hablitz J.J. Zinc and zolpidem modulate mIPSCs in rat neocortical pyramidal neurons. Journal of Neurophysiology. 80:1998;1670-1677.
7. Fenwick E.M., Marty A., Neher E. A patch-clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine. Journal of Physiology (London). 331:1982;577-597.
8. Gasior M., Carter R.B., Witkin J.M. Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. Trends in Pharmacological Sciences. 20:1999;107-112.
9. 3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. Journal of Neurochemistry. 44:1985;1685-1696.
10. Harrison N.L., Vicini S., Barker J.L. A steroid anesthetic prolongs inhibitory postsynaptic currents in cultured rat hippocampal neurons. Journal of Neuroscience. 7:1987;604-609.
11. Kaneda M., Farrant M., Cull-Candy S.G. Whole-cell and single-channel currents activated by GABA and glycine in granule cells of the rat cerebellum. Journal of Physiology (London). 485:1995;419-435.
12. Kruse H.J., Kuch H. Etifoxine: evaluation of its anticonvulsant profile in mice in comparison with sodium valproate, phenytoin and clobazam. Arzneimittelforschung. 35:1985;133-135.
13. A receptor function. Trends in Pharmacological Sciences. 16:1995;295-303.
14. 3H]PK 11195, by thermodynamic studies. Life Sciences. 33:1983;449-457.
15. Lewin A.H., de Costa B.R., Rice K.C., Skolnick P. meta- and para-Isothiocyanato-t-butylbicycloorthobenzoate: irreversible ligands of the gamma-aminobutyric acid-regulated chloride ionophore. Molecular Pharmacology. 35:1989;189-194.
16. 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. Molecular Pharmacology. 21:1982;301-314.
17. A receptor channels. Annual Reviews in Neuroscience. 17:1994;569-602.
18. A receptor. Mechanism of action and physiological significance. Progress in Neurobiology. 38:1992;379-395.
19. Malcangio M., Bowery N.G. GABA and its receptors in the spinal cord. Trends in Pharmacological Sciences. 17:1996;457-462.
20. A receptors. Brain Research: Brain Research Reviews. 29:1999;196-217.
21. Mensah-Nyagan A.G., Do-Rego J.L., Beaujean D., Luu-The V., Pelletier G., Vaudry H. Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacological Reviews. 51:1999;63-81.
22. Oke B.O., Suarez-Quian C.A., Riond J., Ferrara P., Papadopoulos V. Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex. Molecular and Cellular Endocrinology. 87:1992;R1-6.
23. Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocrinology Reviews. 14:1993;222-240.
24. A receptors in central synapses. Journal of Neuroscience. 19:1999;578-588.
25. A receptor-mediated IPSCs by neuroactive steroids in a rat hypothalamo-hypophyseal coculture model. Journal of Physiology (London). 500(Part 2):1997;475-485.
26. 2+ dependence of spontaneous IPSCs. Journal of Neuroscience. 16:1996;4835-4845.
27. A receptor subunit for benzodiazepine pharmacology. Nature. 338:1989;582-585.
28. Robel P., Beaulieu E.E. Neurosteroids: biosynthesis and function. Trends in Endocrinology and Metabolism. 5:1994;1-7.
29. Rybalchenko V., Schlichter R. Functional high- and low-affinity agonist binding sites at native dorsal horn AMPA receptors. Neuroreport. 10:1999;1803-1806.
30. Servant D., Graziani P.L., Moyse D., Parquet P.J. Traitement du trouble de l'adaptation avec anxiété: évaluation de l'efficacité et de la tolérance de l'étifoxine par un essai en double aveugle contre produit de référence. L'Encéphale. 24:1998;569-574.
31. Shank R.P., Baldy W.J., Mattucci L.C., Villani F.J. Jr. Ion and temperature effects on the binding of gamma-aminobutyrate to its receptors and the high-affinity transport system. Journal of Neurochemistry. 54:1990;2007-2015.
32. Sieghart W. Structure and pharmacology of gamma-aminobutyric acid A receptor subtypes. Pharmacological Reviews. 47:1995;181-234.
33. A receptors. Trends in Pharmacological Sciences. 18:1997;425-429.
34. 3H-muscimol for GABA receptor studies. Nature. 273:1978;392-394.
35. 3H]flunitrazepam binding. Life Sciences. 24:1979;351-357.
36. 3H]Nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. Journal of Pharmacology and Experimental Therapeutics. 260:1992;427-436.
37. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E.et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proceedings of the National Academy of Sciences of the United States of America. 95:1998;3239-3244.
38. 2+ into quantal release. Neuroscience Letters. 158:1993;125-129.
39. Vogel J.R., Beer B., Clody D.E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia. 21:1971;1-7.
40. A receptor subunit mRNAs in rat lumbar spinal cord. Brain Research: Molecular Brain Research. 10:1991;179-183.
41. A receptors. Journal of Neuroscience. 16:1996;6648-6656.